Back to Search

ERIC SMALL, MD

MD

Internal Medicine Physician

NPI: 1437117454IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

G61618(CA)
Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

G61618(CA)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

G61618(CA)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Additional

INTERNAL MEDICINE

Education

CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY

Class of 1985

Research & Publications (20)

A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer.
PMID 17822457·BJU Int·2007
3-trial
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
PMID 17606721·Clin Cancer Res·2007
3-trial
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.
PMID 17363537·Clin Cancer Res·2007
3-trial
The case for secondary hormonal therapies in the chemotherapy age.
PMID 17084172·J Urol·2006
6-review
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.
PMID 16809734·J Clin Oncol·2006
3-trial
Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
PMID 16740791·Clin Cancer Res·2006
6-review
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.
PMID 16690359·Mol Ther·2006
3-trial
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
PMID 15020604·J Clin Oncol·2004
3-trial
Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.
PMID 14581438·J Clin Oncol·2003
3-trial
Overview of bladder cancer trials in the Cancer and Leukemia Group B.
PMID 12673701·Cancer·2003
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1600 DIVISADERO ST
SAN FRANCISCO, CA 94115

Quick Facts

NPI
1437117454
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
41
Publications
20

Are you this provider?

Claim Your Profile